Cellular dierentiation frequently involves sequential peaks in the expression of cyclin-dependent kinase inhibitors (cdki's). For example, an increase in levels of the cdki p27Kip1 follows upregulation of p21Waf1 in several cell types induced to dierentiate by diverse stimuli. In this study, we have investigated whether p21Waf1 expression itself, rather than the dierentiating agent, could be increasing p27Kip1 protein levels. We used an inducible p21Waf1 expression vector in a K562 leukemic cell model which we had previously shown to initiate dierentiation following p21Waf1 upregulation. The current study reports that p21Waf1 upregulated p27Kip1 protein without altering p27Kip1 mRNA levels. This eect did not depend on G1-phase arrest ± the increase in p27Kip1 occurred at all phases of the cell cycle. p21Waf1-expressing extracts inhibited phosphorylation of p27Kip1 on threonine-187, leading to decreased ubiquitination and decreased proteasomal destruction of p27Kip1. In K562 cells, upregulation of p27Kip1 by p21Waf1 during dierentiation facilitated an ordered transition between these two cdki's, each of which may distinctly in¯uence the dierentiation process. Oncogene (2001) 20, 6524 ± 6530.
Introduction
Cell cycle progression is modulated by the action of cyclin-dependent kinases (cdk's) which form complexes with cyclins at discrete points in the cell cycle. Cell cycle progression mediated by cyclin E-Cdk2 is opposed by the cdk-inhibitors (cdki's) p21Waf1 and p27Kip1, each of which binds directly both to cyclins and to cdks to downmodulate kinase activity (Russo et al., 1996) . The opposing actions of cyclin-cdk2 complexes and cdki's modulate the cellular commitment to proliferate in the presence of environmental in¯uences such as growth factors or serum deprivation.
Several strategies have emerged through which cells overcome the constraints on growth imposed by cdki's. One mechanism is to redirect cdki binding to cyclin Dcdk4 complexes (Baldassarre et al., 1999; Soos et al., 1996) . These complexes can remain active when bound by p21Waf1 and p27Kip1 and thereby sequester these cdki's in replicating cells (Blain et al., 1997; Tsutsui et al., 1999; Hsieh et al., 2000) . The constraints to cycling imposed by cdki's are also overcome by degradation of p27Kip1. p27Kip1 levels decrease dramatically when certain quiescent cells are induced by mitogens to enter the cell cycle (Coats et al., 1996) .
The level of p27Kip1 protein is regulated posttranscriptionally by the ubiquitin-proteasome pathway (Alessandrini et al., 1997; Pagano et al., 1995; Tam et al., 1997) . p27Kip1 protein degradation is initiated by phosphorylation of p27Kip1 at threonine 187 by cyclin E-cdk2 (Morisaki et al., 1997; Shea et al., 1997) . Recent evidence indicates that both phosphorylated and unphosphorylated p27Kip1 bind tightly to cyclin E-cdk2, and that the p27Kip1 which is present in this cyclinE/cdk2/ p27Kip1 ternary complex is phosphorylated by free cdk2/cyclin E complexes (Xu et al., 1999) . Phosphorylation is followed by shuttling of p27Kip1 into the cytoplasm as part of a complex with the jab1 protein (Tomoda et al., 1999) . This translocation of p27Kip1 coincides with p27Kip1 ubiquitination and subsequent proteasomal degradation (Muller et al., 1997) .
p21Waf1 inhibits cdk2-cyclin complexes in vitro; however, the expression of p21Waf1 frequently is elevated in cycling cells. During the transition out of cellular quiescence, p21Waf1 and p27Kip1 levels change in opposite directions. p21Waf1 levels are low in quiescent cells, and increase when resting cells are stimulated with mitogens (Mantel et al., 1996; Steinman et al., 1998) .
While stimulation of quiescent cells leads to opposite regulation of p21Waf1 and p27Kip1, these cdki's are coordinately upregulated in the setting of dierentiation. For example, increased expression of both p21Waf1 and p27Kip1 protein has been observed upon dierentiation of myeloid cells, prostate cells, glioma, oligodendrocytes and erythroid progenitors (Chen et al., 1999; Ghiani et al., 1999; Harvat et al., 1998; Muto et al., 1999; Panzenbock et al., 1998; Zi and Agarwal, 1999) and in vitamin D-induced arrest of tumor cells (Kawa et al., 1997) . In normal keratinocyte (Harvat et al., 1998) and megakaryocyte (Taniguchi et al., 1999; Urashima et al., 1997) dierentiation, p21Waf1 upregulation immediately precedes increased levels of p27Kip1 protein. In this report we have investigated whether p21Waf1 expression itself, rather than the dierentiating agent, could be increasing p27Kip1 protein levels.
In order to study the eect of p21Waf1 expression on p27Kip1, we utilized an inducible p21Waf1 expression construct in the myeloid cell line K562. K562 cells lack wild-type p53 and have very low endogenous levels of p21Waf1. We have shown that exogenous p21Waf1 initiates dierentiation in this cell model (Steinman et al., 2000) . The studies reported below demonstrate that p21Waf1 expression upregulated p27Kip1 protein levels in K562 cells, most likely by decreasing phosphorylation of p27Kip1 at threonine 187.
Results

p21Waf1 induces p27Kip1 protein levels
p27Kip1 expression was examined in K562 IWAF cells. These are K562 cells stably transfected with p21Waf1 expression plasmids under the control of the lac Z repressor which are induced to express p21Waf1 when IPTG is added to the medium. As previously described (Steinman et al., 2000) , these cells express p21Waf1 within 6 h of IPTG addition, reaching a peak level at 24 h following addition. The levels achieved under our experimental conditions were comparable to p21Waf1 levels achieved as a result of exposure to dierentiation inducers. As shown in Figure 1a , p27Kip1 RNA was unaltered by the induction of p21Waf1. In contrast, a signi®cant rise in the expression of p27Kip1 protein was evident within 24 h. This eect was repeatable in several independently-derived K562 IWAF subclones, and was sustained through 4 days of p21Waf1 induction (data not shown).
Because p27Kip1 degradation occurs through the proteasome, we compared p27Kip1 upregulation by p21Waf1 with that mediated by proteasome inhibitors. Cells were incubated for 6 h with the speci®c proteasome inhibitors lactacystin (L) and epoxomicin (E) (Meng et al., 1999) following overnight preincubation with or without IPTG. Figure 1b shows total protein levels for ubiquitin, p27Kip1, and p21Waf1 under these conditions. As expected, the proteasome inhibitors increased the steady-state level of ubiquitinated proteins in the cell. Induction of p21Waf1 by IPTG did not alter the level of total protein ubiquitination. This con®rmed that p21Waf1 was not sustaining p27Kip1 protein by decreasing proteasomal function on a global basis. In cells in which p21Waf1 was not induced, the expression of p27Kip1 was increased between four and sevenfold by proteasome inhibitors in two independent experiments. On the other hand, in cells in which p27Kip1 had been induced by p21Waf1, the addition of proteasome inhibitors did not substantially alter p27Kip1 expression (range 0.7 ± 1.3-fold). This indicated that p27Kip1 degradation was already maximally inhibited by p21Waf1 under these conditions. In contrast, proteasome inhibitors further increased the expression of p21Waf1 itself by twofold when added to IPTGexposed cells.
p27Kip1 binds to cdk2 and to cdk4 following p21Waf1 induction
We next considered whether the increased stability of p27Kip1 resulted from the fact that induced p21Waf1 sequestered cellular cdk2 and made it unavailable to p27Kip1. Phosphorylation of p27Kip1 by cyclinE-cdk2 marks p27Kip1 for degradation by the ubiquitinproteasome complex, and inaccessibility of cdk2 complexes to p27Kip1 could thereby raise the steadystate level of p27Kip1 protein. As shown in Figure 2 , cdk2 protein was bound to both p21Waf1 and p27Kip1 in p21Waf1-induced cells. There was a partial shift from p27Kip1-cdk2 complex formation to p27Kip1-cdk4 complex formation after p21Waf1 induction: whereas in the absence of IPTG, immunoprecipitated cdk2 exhibited 1 3 the signal intensity of immunoprecipitated cdk4, it exhibited 1 5 the signal of cdk4 after p21Waf1 induction. In contrast, the partitioning of p21Waf1 between cdk2 and cdk4 did not change after IPTG addition. Conceivably, a shift in binding partners from cdk2 to cdk4 could contribute to p27Kip1 stability in IPTG-exposed cells. This was unlikely to be the underlying mechanism of p27Kip1 upregulation however, because after IPTG-addition there was a 3.9-fold increase in the amount of cdk2-p27Kip1 complexes. Figure 2b also demonstrates that (7) or induced (+IPTG) to express p21Waf1 were harvested at indicated times and blotted for expression of p27Kip1 mRNA and protein. (b) Eect of proteasome inhibitors on p27Kip1 induction. Cells were exposed to medium alone or to IPTG for 20 h, following which they were exposed for 6 h to DMSO control (D) or to the proteasome inhibitors lactacystin (10 uM, L) or epoxomycin (5 uM, E) as indicated. Uninduced (7) and p21Waf1-expressing (+) cells were harvested and extracts were blotted for p27Kip1, p21Waf1 and ubiquitin as shown. An increase in total ubiquitinated protein is evident in proteasome-inhibited lanes. Experiments conducted with a mass culture of inducible p21Waf1-transfected K562 cells (mc) and with a subclone of that culture (c1) are shown. Molecular weights are indicated to the right of the Figure p21Waf1 and p27Kip1 did not exist in a binding complex with each other.
Constitutive phosphorylation of p27Kip1 in K562 cells
The above results indicated that p27Kip1 which had been induced by p21Waf1 was not a substrate for the proteasome (e.g. proteasome inhibitors did not further increase p27Kip1 levels). The results also showed that p21Waf1 did not act solely by sequestering cdk2 so that it was unavailable to p27Kip1. This raised the prospect that p27Kip1 phosphorylation and resultant ubiquitination might be suppressed by p21Waf1. In order to determine this, we ®rst characterized p27Kip1 phosphorylation on Thr-187 in K562 cells, using an antibody directed against a phosphorylated Thr-187-containing epitope in p27Kip1. Immunoblotting K562 extracts with this antibody was not sensitive enough to detect phosphorylation. In order to optimize detection of p27Kip1 phosphorylating activity within p21Waf1-expressing and non-expressing extracts, we used an in vitro ubiquitination assay. This assay has been used to measure ubiquitination in vitro and also has been useful for measuring phosphorylation of p27Kip1 in vitro (Montagnoli et al., 1999) . The assay utilizes an ATP-regenerating system and provides a sensitive measure of the phosphorylation of recombinant p27Kip1 by cell extracts. Figure 3a demonstrates the use of this assay with HeLa cell exposed for 12 h to medium alone or to medium containing nocodazole. The microtubule-destabilizing drug nocodazole has been reported to increase p27Kip1 phosphorylation and ubiquitination in vitro (Montagnoli et al., 1999) . We probed untreated and nocodazole-treated HeLa cell extracts with antibody directed against p27Kip1 and with antibody speci®c for p27Kip1 phosphorylated on threonine 187. It is evident that nocodazole markedly decreases levels of endogenous p27Kip1 (lane 2 compared with 1). Increased levels of polyubiquitinated, high molecular weight p27Kip1 proteins are also evident in extracts treated with nocodazole and probed with antibody to phospho-p27Kip1. When these extracts were incubated with recombinant p27Kip1 in the in vitro phosphorylation mix, there was a marked increase in phosphorylated p27Kip1 in the reaction mixture containing extract from nocodazole-treated cells (lane 5 compared with 4). Figure 3b utilizes the same system to analyse K562 cells. It was evident that, unlike HeLa cells, K562 cells constitutively expressed high levels of an activity capable of phosphorylating p27Kip1 on Thr-187. Both the cell extract and the ubiquitination reaction mix were necessary for phosphorylation of recombinant p27Kip1 to proceed.
p21Waf1 induction decreases phosphorylation of p27Kip1 by K562 extracts
The eect of p21Waf1 induction on phosphorylation of p27Kip1 was then studied in this in vitro ubiquitination system. An excess of murine recombinant p27Kip1 was incubated with uninduced or induced K562 extracts for 15 or for 60 min (Figure 4a ). It was apparent that phosphorylation of the recombinant p27Kip1 is signi®cantly reduced at both timepoints when it was incubated with p21Waf1-expressing extracts (lane 4 vs 3 and 10 vs 9). The presence of MG132, which inhibits proteasomal destruction of p27Kip1, did not alter the decrease in phosphorylation in p21Waf1-expressing extract mixtures. This indicated that proteasomal destruction did not account for the decrease of Figure 2 Association of p27Kip1 and p21Waf1 with cdks. K562 IWAF cells treated with medium (U) or IPTG (I) for 24 h were harvested, and extracts were immunoprecipitated with polyclonal p27Kip1, polyclonal p21Waf1, or with control rabbit serum as indicated. Immunoprecipitates were fractionated on 12.5% acrylamide and blotted with antibodies against p27Kip1, cdk2 or cdk4 as shown. Control immunoprecipitates with serum were negative (not shown). The ratio of IPTG-induced to uninduced signal strength is shown to the right of each blot Figure 3 In vitro phosphorylation of p27Kip1. (a) Hela cell extracts. Extracts of HeLa cells exposed to medium alone (+) or medium containing 2 uM nocodazole were prepared using a nitrogen bomb and were assayed for their ability to phosphorylate p27Kip1. Fifty ug of extracts were incubated for 15 min with in vitro ubiquitination mix and 50 ng of recombinant p27Kip1 as indicated. Blots were probed with HRP-conjugated anti-p27Kip1 (a-p27Kip1, Transduction laboratories) or with anti-p27Kip1 phospho-Threonine-187 (pp27Kip1, Zymed laboratories). High molecular weight polyubiquitinated p27Kip1 species are indicated with brackets (hmw). (b) K562 cell extract. K562 IWAF cells were extracted using a nitrogen bomb, and 50 ug of extract was incubated with 25 ng recombinant p27Kip1 and ubiquitination mix (Ub mix) as indicated. Slightly lower p27Kip1 signal in lanes 1 and 3 re¯ects partial absorption of recombinant p27Kip1 to the reaction tube. Reaction mixtures were fractionated on a 15% gel and blotted with antibody directed against p27Kip1-phosphoThr-187 (pp27Kip1) or total p27Kip1 (p27Kip1HRP) as indicated phospho-p27Kip1. Figure 4b compares the eect of p21Waf1 induction with the eect of roscovitine, a speci®c inhibitor of cdk2 kinase activity. The amount of phosphorylated p27Kip1 was decreased both by p21Waf1 (lane 5 vs 4) and by roscovitine (lane 7 vs 4, 8 vs 5). Ubiquitinated p27Kip1 was also decreased in the p21Waf1-induced extract, as shown by the decrease in high molecular weight (hmw) forms of p27Kip1. Decreased ubiquitination also was demonstrated by immunoprecipitating with ubiquitin and blotting with p27Kip1 ( Figure 4c ). The decreased ubiquitination of p27Kip1 was most likely to result from the decreased phosphorylation of p27Kip1 in the presence of p21Waf1.
p21Waf1-induction of p27Kip1 is cell cycle independent
It is conceivable that the induction of p27Kip1 by p21Waf1 is a direct result of G1-phase growth arrest eected by p21Waf1. In order to address this, we determined p27Kip1 expression levels separately in cells at each cell cycle phase in order to establish whether cells arrested in G1 phase accounted for all of the increase in p27Kip1. Figure 5 shows¯ow cytometric data on cells which were doubly stained for p27Kip1 and for DNA content. G1 phase arrest after p21Waf1 induction was evident ( Figure 5, top) . Analysis of the p27Kip1 content of cells in each cell cycle phase demonstrates that p27Kip1 was elevated in all cell cycle phases after p21Waf1 induction (Figure 5 , bottom; Table 1 ). These ®ndings indicate that the induction of p27Kip1 by p21Waf1 was not merely the result of cell cycle arrest.
Discussion
In this report, we demonstrate for the ®rst time the upregulation of p27Kip1 protein by induction of the p21Waf1 cell cycle regulator in cells. This ®nding indicates that the coupled upregulation of p21Waf1 and p27Kip1 which is frequently seen during dierentiation need not arise from distinct eects of dierentiating agents on both of these cell cycle regulators. Coordinated expression of p21Waf1 and p27Kip1 may instead result from a direct eect of p21Waf1 on p27Kip1 protein stability. or induced (I) to express p21Waf1 for 24 h were extracted and ubiquitinated species were immunoprecipitated, followed by blotting for p27Kip1. Two independent experiments are shown Figure 5 Cell cycle independence of p27Kip1 induction. K562 IWAF cells incubated with medium alone (7) or IPTG for 20 h were doubly stained with propidium iodide for DNA content and with monoclonal anti-p27Kip1 antibody. Top: Cell cycle pro®les of uninduced (7) and induced (IPTG) cells. Bottom: p27Kip1 expression compared between uninduced and induced G1, G2, and S phase cells as indicated. Histograms of cells in which p21Waf1 had been induced are solid The mean log intensity of p27Kip1¯uorescence in the presence and absence of induced p21Waf1 is shown for each cell cycle phase Cdk-inhibitors have been shown to exert in¯uences on dierentiation distinct from their eects on cell cycle control (Casini and Pelicci, 1999; Huss et al., 1999; Snowden et al., 2000) . In a number of cells, the expression of dierent cdki's peak at dierent points during the dierentiation process and then decline. For instance, during normal keratinocyte dierentiation, p21Waf1 upregulation is followed within hours by increased p27Kip1 expression. As dierentiation proceeds, p21Waf1 (but not p27Kip1) levels decline. Forced expression of p21Waf1 during the ®nal phases of keratinocyte dierentiation has been shown to inhibit the progression to terminal dierentiation (Di Cunto et al., 1998) . The initiation of p27Kip1 upregulation by p21Waf1 could choreograph an ordered transition between two cdki's, each of which couple a de®ned stage of dierentiation to a given level of cell cycle control.
Our investigations support a fairly clearcut mechanism through which p21Waf1 upregulation of p27Kip1 could occur. We propose that p21Waf1 inhibits the phosphorylation of p27Kip1 on threonine-187 by cyclincdk2 complexes, and that this in turn decreases p27Kip1 ubiquitination and subsequent proteasomal degradation of p27Kip1. Our data demonstrated decreased ubiquitination of p27Kip1 in K562 cells induced to express p21Waf1. This was speci®c to p27Kip1 and was not a global eect of p21Waf1 on ubiquitination. We used an in vitro system in order to detect alteration of p27Kip1 phosphorylation in the presence of p21Waf1-expressing and non-expressing extracts. These studies demonstrated that phosphorylation of p27Kip1 at Thr-187 was decreased by p21Waf1-expressing extracts. It is notable that Nguyen et al. (1999) recently reported that p27Kip1 levels decreased in an in vitro degradation assay and that recombinant p21Waf1 stabilized p27Kip1 in that system. Our results suggest that p21Waf1 stabilized p27Kip1 by inhibiting its phosphorylation in those studies. Our report also indicates that p21Waf1 may aect p27Kip1 similarly in living cells.
While this mechanism for p27Kip1 stabilization is relatively straightforward, an interesting model arises from consideration of the data. First of all, it does not appear that the modulation of p27Kip1 levels by p21Waf1 arises simply by sequestration of cdk2 by p21Waf1, making it unavailable for p27Kip1 phosphorylation. In cells in which p27Kip1 levels are induced, p27Kip1-cdk2 complex formation increases also. Our ®ndings are consistent with the studies recently published by Xu et al. (1999) on the mechanism of p27Kip1 phosphorylation. These studies showed that p27Kip1 within cyclin-cdk2 complexes is the substrate for phosphorylation, but is not phosphorylated by the complex to which it is bound. Rather,`free' cdk2-cyclin complexes phosphorylate the bound p27Kip1. In keeping with this model, we propose that induced p21Waf1 associates with`free' cdk2-cyclin complexes and inhibits the ability of this complex to phosphorylate p27Kip1, even though the p27Kip1 is already bound in a complex with cdk2.
We found that p21Waf1 increased p27Kip1 levels at all phases of the cell cycle. Cell-free assay systems have demonstrated that G1-enriched extracts inhibit p27Kip1 degradation (Montagnoli et al., 1999; Nguyen et al., 1999) . These mechanisms are likely to be important in cells such as B cells in which the expression of p27Kip1 is highest in G0/G1 phase (Hengst and Reed, 1996; Wagner et al., 1998) . Other cell types, including many cancers, express high levels of p27Kip1 throughout the cell cycle. Stable expression of p27Kip1 in the cytoplasm of cancer cells (Orend et al., 1998) may result from concurrent expression of p21Waf1.
A remaining issue is why p21Waf1 doesn't induce p27Kip1 in all settings. In particular, why do p21Waf1 and p27Kip1 levels progress in opposite directions as cells leave quiescence? We suspect that the inability of the induced p21Waf1 to obviate p27Kip1 downmodulation results from additional factors present in cells exiting quiescence which modulate p21Waf1 interactions with cdk2. Recently, one such factor, SET (Estanyol et al., 1999) has been shown to block p21Waf1 inhibition of cyclinE-cdk2 without altering p21Waf1 binding to the complex. Future investigations should clarify this issue.
Cellular dierentiation involves sequential peaks of cdk-inhibitor expression (Franklin and Xiong, 1996; Morrison and Farmer, 1999; Tian and Quaroni, 1999) . Indeed, there is a growing appreciation of a role for these proteins in dierentiation control, independent of their eects on the cell cycle (Casini and Pelicci, 1999) (de Koning et al., 2000) . The induction of p27Kip1 protein by p21Waf1 is one example of how the expression of several of these cdki's can directly be coupled. Because cdki's exhibit dierences in subcellular compartmentalization and in binding partners in dierent tissues, it is unclear whether stabilization of p27Kip1 by p21Waf1 will be generalizable to all cells. Other regulatory controls on p27Kip1 levels may predominate in other settings. For example, retinoic acid inhibits p27Kip1 degradation independently of p21Waf1 (Baldassarre et al., 2000) , bcl-2 enhances p27Kip1 translation (Vairo et al., 2000) , and stat-3 upregulates transcription of p27Kip1 (de Koning et al., 2000) . This does not obviate the probability that stabilization of p27Kip1 by p21Waf1 is a signi®cant physiologic mechanism employed in many settings. This is further supported by the recent report that antisense p21Waf1 prevents p27Kip1 upregulation by IL-4 in astroglioma cells (Liu et al., 2000) . It is likely that in many cellular lineages the direct stabilization of p27Kip1 by p21Waf1 helps to coordinate the dierentiation-speci®c functions of these proteins.
Materials and methods
Reagents
Monoclonal antibodies included anti-cdk2 (Labvision, Fremont, CA, USA), anti-cdk4 (Labvision), anti-ubiquitin (PD41, Santa Cruz, CA, USA) and HRP-conjugated antip27Kip1 (p27Kip1HRPO, Transduction laboratories, San Diego, CA, USA). Polyclonal antibodies included anti-murine p27Kip1 (Labvision) and anti phospho-p27Kip1 (Zymed Laboratories, San Francisco, CA, USA). Murine recombinant p27Kip1 was purchased from Pharmingen (San Diego, CA, USA). Other reagents included IPTG (Boehringer Mannheim) and MG132, LNLL, and clasto-lactacystin (Calbiochem). Reagents used in the in vitro phosphorylation assay were obtained from Calbiochem, San Diego, CA, USA (methyl-ubiquitin, ubiquitin aldelhyde, ATP, okadaic acid), or from ICN Biomedicals, Costa Mesa, CA, USA (Creatine phosphate, creatine phosphokinase).
Cells
K562 IWAF cells were prepared by transfecting K562 cells with a murine p21Waf1 expression plasmid under the control of the lac repressor (Stratagene, La Jolla, CA, USA). Individual clones were isolated under neomycin and hygromycin and characterized. All of these clones and their isolation have been described elsewhere (Steinman et al., 2000) . The eects described in this report were reproduceable in three independent clones (clones 1, 2, and 3); the clone represented in Figures is clone 1 unless otherwise indicated. These cell lines reliably induce p21Waf1 in all cells within 6 h of IPTG exposure. Cells were maintained in log phase growth in RPMI containing 10% heat-inactivated fetal bovine serum, 300 ug/ml hygromycin, 700 ug/ml neomycin, 100 U/ml streptomycin and 100 U/ml penicillin. IPTG was added to a ®nal concentration of 2 mM as indicated in experiments.
In vitro phosphorylation assay
We studied in vitro phosphorylation using the in vitro ubiquitination assay as described in Montagnoli et al. (1999) . Cell extracts were prepared using a nitrogen-disruption bomb (Parr, Moline, IL, USA). Approximately 10 million HeLa or K562 cells were washed and resuspended in 200 ul of buer comprised of 20 mM Tris (pH 7.2), 2 mM DTT, 0.25 mM EDTA, 1 mM NaVO3, and 0.2% protease inhibitor cocktail (Sigma, St. Louis, IL, USA). This was transferred to the bomb chamber which was kept on ice, and a pressure of 1000 p.s.i. of nitrogen was applied. After 30 min, the pressure was released rapidly, and lysed cells were collected and centrifuged in an Eppendorf tube at 10 000 g for 10 min. Protein content of the supernatent was determined. Fifty ug of this extract was used in the in vitro assay. It was incubated with 25 ± 50 ng of recombinant murine p27Kip1 in a mixure containing 40 mM Tris, pH 7.6, 5 mM MgCl2, 1 mM DTT, 10% glycerol, 1 uM ubiquitin aldehyde, 1 mg/ml methyl ubiquitin, 10 mM creatine phosphate, 0.1 ug/ml creatine kinase, 0.5 mM ATP, 1 uM okadaic acid. Reactions were incubated at 308 for 15 ± 60 min and stopped by the addition of Laemmli sample buer.
Flow cytometry
Flow cytometry measuring DNA content and p27Kip1 expression simultaneously were performed as previously described (Yaroslavskiy et al., 1999) , using an Epics XL¯ow cytometer (Coulter, Miami, FL, USA). Data were analysed using a system 2 software package (Coulter).
Western blotting
At indicated time points, cells were extracted either with high salt buer as described (Steinman et al., 1998) or, when used in in vitro phosphorylation assay, were lysed using a nitrogen bomb (Parr Instrument Co., Moline, IL, USA). Extracts were assayed for protein concentration using BCA (Pierce Inc., Rockford, IL, USA) per the manufacturer's instructions and equal microgram amounts of extracts (or, in the case of the in vitro assay, equal portions of the assay mixture) were fractionated on 12.5 or 15% SDS ± PAGE gels and transferred to membranes (Protran, Schleicher and Schuell) using standard techniques. Membranes were immunoblotted for 1 h with p27Kip1-HRPO (Transduction laboratories) at 1 : 2500, with rabbit anti-mouse p27Kip1 (Ab-2, Labvision, Fremont, CA, USA) or with monoclonal anti-ubiquitin (sc-8017) at 1 ug/ml. p27Kip1-HRPO is strongly reactive against both human and murine p27Kip1. Rabbit anti-p27Kip1 phospho-Thr187 (Zymed) was used at 2 ug/ml. Secondary antibodies were incubated at a 1 : 10 000 dilution for 45 min as indicated and blots were developed using ECL (Amersham). Densitometric analyses were performed on a Molecular Dynamics densitometer equipped with ImageQuant software.
Immunoprecipitation
Ten million cells were lysed in immunoprecipitation buer containing phosphatase and protease inhibitor cocktails (Sigma). Debris was removed by centrifugation and lysates were precleared with protein A/G plus (Santa Cruz). They were incubated overnight at 48 with antibodies at 2 ug/ml and subsequently incubated with protein A/G beads for 2 h. Antibodies used to immunoprecipitate included polyclonal anti-ubiquitin (sc-9133, Santa Cruz), anti-p27Kip1 (sc-528) or anti-p21Waf1 (sc-397). Protein was precipitated on beads with gentle centrifugation at 2000 r.p.m.; beads were subsequently washed ®ve times in lysis buer and protein then eluted into Laemmli buer for Western blotting.
